Adjuvant chemotherapy in rectal cancers: why a standard in the US and not in Europe?
- 1 December 2004
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 1 (2) , 58-59
- https://doi.org/10.1038/ncponc0042
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy of Oral Adjuvant Therapy After Resection of Colorectal Cancer: 5-Year Results From Three Randomized TrialsJournal of Clinical Oncology, 2004
- Adjuvant therapy for rectal cancer – the transatlantic viewColorectal Disease, 2003
- A Systematic Overview of Radiation Therapy Effects in Rectal CancerActa Oncologica, 2003
- Has Progress Been Made in Gastrointestinal Cancer Treatment?Acta Oncologica, 2002
- Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and IIIBritish Journal of Cancer, 2001
- Chemoradiotherapy for rectal cancer – is there an optimal combination?Annals of Oncology, 2001
- A Systematic Overview of Chemotherapy Effects in Colorectal CancerActa Oncologica, 2001
- Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancerThe Lancet, 2000
- Treatment Systems Guidelines for Primary Rectal Cancer From the 1996 Patterns of Care StudyInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Adjuvant Therapy for Patients With Colon and Rectal CancerJAMA, 1990